Redox Homeostasis in Muscular Dystrophies
暂无分享,去创建一个
E. Ricci | S. Petrillo | G. Tasca | M. Monforte | F. Piemonte | N. Mosca | S. Bortolani
[1] E. Ricci,et al. Proteomics of Muscle Microdialysates Identifies Potential Circulating Biomarkers in Facioscapulohumeral Muscular Dystrophy , 2020, International journal of molecular sciences.
[2] N. Gueven,et al. Targeting Nrf2 for the treatment of Duchenne Muscular Dystrophy , 2020, Redox biology.
[3] J. Jaiswal,et al. Membrane Repair Deficit in Facioscapulohumeral Muscular Dystrophy , 2020, International journal of molecular sciences.
[4] S. Zierz,et al. Cellular Stress in the Pathogenesis of Muscular Disorders—From Cause to Consequence , 2020, International journal of molecular sciences.
[5] M. Rodríguez-Cruz,et al. Circulating markers of oxidative stress are associated with a muscle injury in patients with muscular dystrophy Duchenne , 2020, Brain and Development.
[6] E. Esposito,et al. Antioxidant and Anti-inflammatory Effect of Nrf2 Inducer Dimethyl Fumarate in Neurodegenerative Diseases , 2020, Antioxidants.
[7] E. Bertini,et al. Oxidative Stress in DNA Repeat Expansion Disorders: A Focus on NRF2 Signaling Involvement , 2020, Biomolecules.
[8] M. Grounds,et al. Biomarkers for Duchenne muscular dystrophy: myonecrosis, inflammation and oxidative stress , 2020, Disease Models & Mechanisms.
[9] O. Slanař,et al. Targeting Keap1/Nrf2/ARE signaling pathway in multiple sclerosis. , 2020, European journal of pharmacology.
[10] J. Dowling,et al. Randomized controlled trial of N-acetylcysteine therapy for RYR1-related myopathies , 2020, Neurology.
[11] F. Koç,et al. Antioxidant imbalance in the erythrocytes of Myotonic dystrophy Type 1 patients. , 2019, Archives of biochemistry and biophysics.
[12] K. O'Halloran,et al. N-acetylcysteine Decreases Fibrosis and Increases Force-Generating Capacity of mdx Diaphragm , 2019, Antioxidants.
[13] A. Pichiecchio,et al. Tracking muscle wasting and disease activity in facioscapulohumeral muscular dystrophy by qualitative longitudinal imaging , 2019, Journal of cachexia, sarcopenia and muscle.
[14] Daniela Sayuri Mizobuti,et al. Coenzyme Q10 supplementation acts as antioxidant on dystrophic muscle cells , 2019, Cell Stress and Chaperones.
[15] P. Brambilla,et al. Preliminary Evidences of Safety and Efficacy of Flavonoids- and Omega 3-Based Compound for Muscular Dystrophies Treatment: A Randomized Double-Blind Placebo Controlled Pilot Clinical Trial , 2019, Front. Neurol..
[16] A. Cuadrado,et al. Activators and Inhibitors of NRF2: A Review of Their Potential for Clinical Development , 2019, Oxidative medicine and cellular longevity.
[17] Min Zhang,et al. Sulforaphane Attenuates Angiotensin II-Induced Vascular Smooth Muscle Cell Migration via Suppression of NOX4/ROS/Nrf2 Signaling , 2019, International journal of biological sciences.
[18] S. Severini,et al. Dynamic transcriptomic analysis reveals suppression of PGC1α/ERRα drives perturbed myogenesis in facioscapulohumeral muscular dystrophy , 2018, Human molecular genetics.
[19] R. Tawil,et al. Facioscapulohumeral Muscular Dystrophy: Update on Pathogenesis and Future Treatments , 2018, Neurotherapeutics.
[20] C. Hidalgo,et al. The signaling pathways underlying BDNF-induced Nrf2 hippocampal nuclear translocation involve ROS, RyR-Mediated Ca2+ signals, ERK and PI3K. , 2018, Biochemical and biophysical research communications.
[21] I. Nishino,et al. A patient-derived iPSC model revealed oxidative stress increases facioscapulohumeral muscular dystrophy-causative DUX4 , 2018, Human molecular genetics.
[22] P. Robledo,et al. Methylphenidate Attenuates the Cognitive and Mood Alterations Observed in Mbnl2 Knockout Mice and Reduces Microglia Overexpression. , 2018, Cerebral cortex.
[23] Katarzyna Pietraszek-Gremplewicz,et al. Heme Oxygenase-1 Influences Satellite Cells and Progression of Duchenne Muscular Dystrophy in Mice. , 2018, Antioxidants & redox signaling.
[24] Masayuki Yamamoto,et al. The KEAP1-NRF2 System: a Thiol-Based Sensor-Effector Apparatus for Maintaining Redox Homeostasis. , 2018, Physiological reviews.
[25] A. Vasconsuelo,et al. Oxidative Stress in Muscle Diseases: Current and Future Therapy , 2018, Oxidative medicine and cellular longevity.
[26] E. Ricci,et al. Muscle Microdialysis to Investigate Inflammatory Biomarkers in Facioscapulohumeral Muscular Dystrophy , 2018, Molecular Neurobiology.
[27] A. Modesti,et al. Proteome analysis in dystrophic mdx mouse muscle reveals a drastic alteration of key metabolic and contractile proteins after chronic exercise and the potential modulation by anti-oxidant compounds. , 2018, Journal of proteomics.
[28] G. Meissner. The structural basis of ryanodine receptor ion channel function , 2017, The Journal of general physiology.
[29] M. Grounds,et al. Pre‐clinical evaluation of N‐acetylcysteine reveals side effects in the mdx mouse model of Duchenne muscular dystrophy , 2017, The Journal of physiology.
[30] D. Manners,et al. Mitochondrial dysfunction in myotonic dystrophy type 1 , 2017, Neuromuscular Disorders.
[31] Daniela Sayuri Mizobuti,et al. Vitamin E treatment decreases muscle injury in mdx mice. , 2017, Nutrition.
[32] A. Michelucci,et al. Antioxidant Treatment Reduces Formation of Structural Cores and Improves Muscle Function in RYR1Y522S/WT Mice , 2017, Oxidative medicine and cellular longevity.
[33] Takafumi Suzuki,et al. Stress-sensing mechanisms and the physiological roles of the Keap1–Nrf2 system during cellular stress , 2017, The Journal of Biological Chemistry.
[34] I. Nonaka,et al. Sialic acid deficiency is associated with oxidative stress leading to muscle atrophy and weakness in GNE myopathy , 2017, Human molecular genetics.
[35] V. Pialoux,et al. Redox Control of Skeletal Muscle Regeneration. , 2017, Antioxidants & redox signaling.
[36] Z. Ulger,et al. Serum markers of inflammation and oxidative stress in sarcopenia , 2017, Aging Clinical and Experimental Research.
[37] E. Bertini,et al. Oxidative stress in Duchenne muscular dystrophy: focus on the NRF2 redox pathway , 2017, Human molecular genetics.
[38] Fu-Tsai Chung,et al. Heat shock protein70 is implicated in modulating NF-κB activation in alveolar macrophages of patients with active pulmonary tuberculosis , 2017, Scientific Reports.
[39] Amy D. Hanna,et al. A chemical chaperone improves muscle function in mice with a RyR1 mutation , 2017, Nature Communications.
[40] Akhileshwar Namani,et al. Nrf2 signaling pathway: Pivotal roles in inflammation. , 2017, Biochimica et biophysica acta. Molecular basis of disease.
[41] Donna D. Zhang,et al. NRF2-targeted therapeutics: New targets and modes of NRF2 regulation. , 2016, Current opinion in toxicology.
[42] Saumya Das,et al. Heme oxygenase and carbon monoxide protect from muscle dystrophy , 2016, Skeletal Muscle.
[43] M. Lipinski,et al. DUX4-induced constitutive DNA damage and oxidative stress contribute to aberrant differentiation of myoblasts from FSHD patients. , 2016, Free radical biology & medicine.
[44] Francesco Muntoni,et al. An RYR1 mutation associated with malignant hyperthermia is also associated with bleeding abnormalities , 2016, Science Signaling.
[45] K. Nakayama,et al. Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription , 2016, Nature Communications.
[46] M. Lipinski,et al. Facioscapulohumeral dystrophy myoblasts efficiently repair moderate levels of oxidative DNA damage , 2016, Histochemistry and Cell Biology.
[47] R. Taneja,et al. Oxidative Stress-Mediated Skeletal Muscle Degeneration: Molecules, Mechanisms, and Therapies , 2015, Oxidative medicine and cellular longevity.
[48] Katarzyna Pietraszek-Gremplewicz,et al. The role of oxidative stress in skeletal muscle injury and regeneration: focus on antioxidant enzymes , 2015, Journal of Muscle Research and Cell Motility.
[49] Takafumi Suzuki,et al. Molecular basis of the Keap1-Nrf2 system. , 2015, Free radical biology & medicine.
[50] B. Engelen,et al. RYR1‐related myopathies: a wide spectrum of phenotypes throughout life , 2015, European journal of neurology.
[51] Dejia Li,et al. Sulforaphane Attenuates Muscle Inflammation in Dystrophin-deficient mdx Mice via NF-E2-related Factor 2 (Nrf2)-mediated Inhibition of NF-κB Signaling Pathway* , 2015, The Journal of Biological Chemistry.
[52] S. Movafagh,et al. Regulation of Hypoxia‐Inducible Factor‐1a by Reactive Oxygen Species : New Developments in an Old Debate , 2015, Journal of cellular biochemistry.
[53] Daniela Sayuri Mizobuti,et al. Effect of N-acetylcysteine plus deferoxamine on oxidative stress and inflammation in dystrophic muscle cells , 2015, Redox report : communications in free radical research.
[54] Ying Zhang,et al. Nrf2 regulates ROS production by mitochondria and NADPH oxidase , 2015, Biochimica et biophysica acta.
[55] J. Pincemail,et al. Effects of vitamin C, vitamin E, zinc gluconate, and selenomethionine supplementation on muscle function and oxidative stress biomarkers in patients with facioscapulohumeral dystrophy: a double-blind randomized controlled clinical trial. , 2015, Free radical biology & medicine.
[56] S. Severini,et al. β-catenin is central to DUX4-driven network rewiring in facioscapulohumeral muscular dystrophy , 2015, Journal of The Royal Society Interface.
[57] S. Iannaccone,et al. Congenital myopathies and muscular dystrophies. , 2014, Neurologic clinics.
[58] M. Tarnopolsky,et al. Redox State and Mitochondrial Respiratory Chain Function in Skeletal Muscle of LGMD2A Patients , 2014, PloS one.
[59] D. Rajakumar,et al. Involvement of oxidative stress, nuclear factor kappa B and the ubiquitin proteasomal pathway in dysferlinopathy. , 2014, Life sciences.
[60] M. Sardiello,et al. Src-dependent impairment of autophagy by oxidative stress in a mouse model of Duchenne muscular dystrophy , 2014, Nature Communications.
[61] E. Mercuri,et al. Upper Girdle Imaging in Facioscapulohumeral Muscular Dystrophy , 2014, PloS one.
[62] F. Di Lisa,et al. Oxidative stress in muscular dystrophy: from generic evidence to specific sources and targets , 2014, Journal of Muscle Research and Cell Motility.
[63] Michael Kyba,et al. High-throughput screening identifies inhibitors of DUX4-induced myoblast toxicity , 2014, Skeletal Muscle.
[64] S. Agarwal,et al. Imbalanced oxidant and antioxidant ratio in myotonic dystrophy type 1 , 2014, Free radical research.
[65] Ching H. Wang,et al. Diagnostic approach to the congenital muscular dystrophies , 2014, Neuromuscular Disorders.
[66] P. Shieh. Muscular dystrophies and other genetic myopathies. , 2013, Neurologic clinics.
[67] M. Grounds,et al. Oxidative stress and pathology in muscular dystrophies: focus on protein thiol oxidation and dysferlinopathies , 2013, The FEBS journal.
[68] D. Rajakumar,et al. Oxidative Stress, NF-κB and the Ubiquitin Proteasomal Pathway in the Pathology of Calpainopathy , 2013, Neurochemical Research.
[69] Yi-Wen Chen,et al. DUX4 Differentially Regulates Transcriptomes of Human Rhabdomyosarcoma and Mouse C2C12 Cells , 2013, PloS one.
[70] J. Lawler,et al. Contribution of oxidative stress to pathology in diaphragm and limb muscles with Duchenne muscular dystrophy , 2013, Journal of Muscle Research and Cell Motility.
[71] B. Vernus,et al. Glutathione peroxidase 3, a new retinoid target gene, is crucial for human skeletal muscle precursor cell survival , 2012, Journal of Cell Science.
[72] C. Reggiani,et al. Inflammation in muscular dystrophy and the beneficial effects of non‐steroidal anti‐inflammatory drugs , 2012, Muscle & nerve.
[73] R. Krahe,et al. The myotonic dystrophies: molecular, clinical, and therapeutic challenges , 2012, The Lancet Neurology.
[74] J. Pincemail,et al. Functional muscle impairment in facioscapulohumeral muscular dystrophy is correlated with oxidative stress and mitochondrial dysfunction. , 2012, Free radical biology & medicine.
[75] J. Y. Kuwada,et al. Oxidative stress and successful antioxidant treatment in models of RYR1-related myopathy. , 2012, Brain : a journal of neurology.
[76] P. Sestili,et al. Reactive Oxygen Species in Skeletal Muscle Signaling , 2011, Journal of signal transduction.
[77] Christopher W Ward,et al. X-ROS Signaling: Rapid Mechano-Chemo Transduction in Heart , 2011, Science.
[78] J. Lainé,et al. Increased Muscle Stress-Sensitivity Induced by Selenoprotein N Inactivation in Mouse: A Mammalian Model for SEPN1-Related Myopathy , 2011, PloS one.
[79] T. Shiomi,et al. Ryanodine receptor oxidation causes intracellular calcium leak and muscle weakness in aging. , 2011, Cell metabolism.
[80] Raffaele Iorio,et al. CD8+ T Cells in Facioscapulohumeral Muscular Dystrophy Patients with Inflammatory Features at Muscle MRI , 2011, Journal of Clinical Immunology.
[81] D. Allen,et al. Skeletal Muscle NADPH Oxidase Is Increased and Triggers Stretch-Induced Damage in the mdx Mouse , 2010, PloS one.
[82] T. Kensler,et al. When NRF2 talks, who's listening? , 2010, Antioxidants & redox signaling.
[83] Daniel G. Miller,et al. A Unifying Genetic Model for Facioscapulohumeral Muscular Dystrophy , 2010, Science.
[84] A. Musarò,et al. Oxidative stress and muscle homeostasis , 2010, Current opinion in clinical nutrition and metabolic care.
[85] M. Ehrlich,et al. Analysis of allele-specific RNA transcription in FSHD by RNA-DNA FISH in single myonuclei , 2010, European Journal of Human Genetics.
[86] A. Ferreiro,et al. Selenoproteins and protection against oxidative stress: selenoprotein N as a novel player at the crossroads of redox signaling and calcium homeostasis. , 2010, Antioxidants & redox signaling.
[87] R. Finkel,et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management , 2010, The Lancet Neurology.
[88] R. Haller,et al. Mitochondrial abnormalities, energy deficit and oxidative stress are features of calpain 3 deficiency in skeletal muscle. , 2009, Human molecular genetics.
[89] F. Muntoni,et al. Oxidative stress in SEPN1‐related myopathy: From pathophysiology to treatment , 2009, Annals of neurology.
[90] M. Kyba,et al. An isogenetic myoblast expression screen identifies DUX4‐mediated FSHD‐associated molecular pathologies , 2008, The EMBO journal.
[91] F. Muntoni,et al. Congenital muscle disorders with cores: the ryanodine receptor calcium channel paradigm. , 2008, Current opinion in pharmacology.
[92] A. E. Rossi,et al. RyR1 S-Nitrosylation Underlies Environmental Heat Stroke and Sudden Death in Y522S RyR1 Knockin Mice , 2008, Cell.
[93] J. Viña,et al. Moderate exercise is an antioxidant: upregulation of antioxidant genes by training. , 2008, Free radical biology & medicine.
[94] L. Morrison. Unraveling RYR1 mutations and muscle biopsies , 2008, Neurology.
[95] Michiaki Yamashita,et al. The muscle-specific ubiquitin ligase atrogin-1/MAFbx mediates statin-induced muscle toxicity. , 2007, The Journal of clinical investigation.
[96] D. Allen,et al. The role of reactive oxygen species in the hearts of dystrophin-deficient mdx mice. , 2007, American journal of physiology. Heart and circulatory physiology.
[97] M. Tarnopolsky,et al. Low intensity training decreases markers of oxidative stress in skeletal muscle of mdx mice. , 2007, Free radical biology & medicine.
[98] G. Vita,et al. RAGE‐NF‐κB pathway activation in response to oxidative stress in facioscapulohumeral muscular dystrophy , 2007 .
[99] S. Hamilton,et al. Identification of Cysteines Involved in S-Nitrosylation, S-Glutathionylation, and Oxidation to Disulfides in Ryanodine Receptor Type 1* , 2006, Journal of Biological Chemistry.
[100] J. Engelhardt,et al. Interleukin-1β Induction of NFκB Is Partially Regulated by H2O2-mediated Activation of NFκB-inducing Kinase* , 2006, Journal of Biological Chemistry.
[101] S. Messina,et al. Oxidative stress in myotonic dystrophy type 1 , 2005, Free radical research.
[102] C. Bisbal,et al. Increased levels of adenine nucleotide translocator 1 protein and response to oxidative stress are early events in facioscapulohumeral muscular dystrophy muscle , 2005, Journal of Molecular Medicine.
[103] Y. Naito,et al. Oxidative stress and delayed-onset muscle damage after exercise. , 2004, Free radical biology & medicine.
[104] P. Brecher,et al. Temporal Control of NF-κB Activation by ERK Differentially Regulates Interleukin-1β-induced Gene Expression* , 2004, Journal of Biological Chemistry.
[105] S. Winokur,et al. Facioscapulohumeral muscular dystrophy (FSHD) myoblasts demonstrate increased susceptibility to oxidative stress , 2003, Neuromuscular Disorders.
[106] P. Hasselgren,et al. IL-1β stimulates IL-6 production in cultured skeletal muscle cells through activation of MAP kinase signaling pathway and NF-κB , 2003 .
[107] Michael R. Green,et al. Inappropriate Gene Activation in FSHD A Repressor Complex Binds a Chromosomal Repeat Deleted in Dystrophic Muscle , 2002, Cell.
[108] M. Karin,et al. Missing Pieces in the NF-κB Puzzle , 2002, Cell.
[109] K. Davies. Oxidative Stress, Antioxidant Defenses, and Damage Removal, Repair, and Replacement Systems , 2000, IUBMB life.
[110] M. Leppert,et al. Congenital muscular dystrophy with rigid spine syndrome: A clinical, pathological, radiological, and genetic study , 2000, Annals of neurology.
[111] S. Ishiura,et al. Differential signaling pathways following oxidative stress in mutant myotonin protein kinase cDNA-transfected C2C12 cell lines. , 2000, Biochemical and biophysical research communications.
[112] R. Foresti,et al. Heme oxygenase-1 induction in skeletal muscle cells: hemin and sodium nitroprusside are regulators in vitro. , 1998, American journal of physiology. Cell physiology.
[113] T. Rando,et al. Muscle cells from mdx mice have an increased susceptibility to oxidative stress , 1998, Neuromuscular Disorders.
[114] Keiko Sato,et al. Free radicals, lipid peroxides and antioxidants in blood of patients with myotonic dystrophy , 1995, Journal of Neurology.
[115] G. Dudley,et al. Influence of exercise and fiber type on antioxidant enzyme activity in rat skeletal muscle. , 1994, The American journal of physiology.
[116] K. Campbell,et al. Dystrophin–glycoprotein complex: Its role in the molecular pathogenesis of muscular dystrophies , 1994, Muscle & nerve.
[117] J E Hewitt,et al. FSHD associated DNA rearrangements are due to deletions of integral copies of a 3.2 kb tandemly repeated unit. , 1993, Human molecular genetics.
[118] J. Weber,et al. Mapping of facioscapulohumeral muscular dystrophy gene to chromosome 4q35-qter by multipoint linkage analysis and in situ hybridization. , 1991, Genomics.
[119] J. Pincemail,et al. [Oxidative stress]. , 2007, Revue medicale de Liege.
[120] I. Hausmanowa-Petrusewicz,et al. The involvement of oxidative stress in determining the severity and progress of pathological processes in dystrophin-deficient muscles. , 2005, Acta biochimica Polonica.
[121] A. Dinkova-Kostova,et al. Protection against electrophile and oxidative stress by induction of phase 2 genes: the quest for the elusive sensor that responds to inducers. , 2004, Advances in enzyme regulation.
[122] S. Hamilton,et al. RyR1 modulation by oxidation and calmodulin. , 2000, Antioxidants & redox signaling.